Lactose intolerance in infants

Cathy Taylor1

  • 1University of Wales, Swansea.

Nursing Times
|May 17, 2006
PubMed

Insights

This article explains lactose intolerance, covering its causes, diagnosis, and treatment. It also details infant management by healthcare teams, focusing on parental advice and nutritional support.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Clinical Nutrition

Background:

  • Lactose intolerance is a common condition affecting infants and children.
  • Understanding the pathophysiology and etiology is crucial for effective management.
  • Primary healthcare teams play a vital role in supporting affected families.

Purpose of the Study:

  • To provide a comprehensive overview of lactose intolerance.
  • To outline diagnostic and treatment strategies.
  • To emphasize the role of primary healthcare in infant management.

Main Methods:

  • Review of the pathophysiology and etiology of lactose intolerance.
  • Discussion of diagnostic approaches.
  • Description of treatment modalities and nutritional support.

Main Results:

  • Lactose intolerance involves the inability to digest lactose, leading to gastrointestinal symptoms.
  • Diagnosis can be achieved through various clinical and laboratory methods.
  • Management strategies focus on dietary adjustments and appropriate nutritional guidance.

Conclusions:

  • Effective management of lactose intolerance requires a thorough understanding of its causes and symptoms.
  • Primary healthcare providers are essential in educating parents and ensuring adequate nutritional intake for infants.
  • Early diagnosis and appropriate intervention can significantly improve outcomes for affected infants.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Inducible Operons: lac Operon01:25

Inducible Operons: lac Operon

The lac operon in Escherichia coli is a model for understanding inducible gene regulation and metabolic flexibility. It integrates local control by lactose and global regulation through catabolite repression, enabling E. coli to preferentially metabolize glucose when available and switch to lactose utilization when glucose is scarce.Structure and Function of the lac OperonThe lac operon contains three structural genes: lacZ (β-galactosidase), lacY (lactose permease), and lacA (thiogalactoside...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...